Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)
Author(s):
Groot, S. de; Charehbili, A.; Laarhoven, H.W.M. van; Mooyaart, A.L.; Dekker-Ensink, N.G.; Ven, S. van de; Janssen, L.G.M.; Swen, J.J.; Smit, V.T.H.B.M.; Heijns, J.B.; Kessels, L.W.; Straaten, R.J.H.M. van der; Bhringer, S.; Gelderblom, A.J. (0000-0001-9270-8636); Hoeven, J.J.M. van der; Guchelaar, H.J.; Pijl, H. (0000-0002-3076-1551); Kroep, J.R.
